Macquarie Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Macquarie Group’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-564	Closed	-$13K	–	2179
2022 Q3	$13K	Sell	564 -71	-11%	-$1.91K	﹤0.01%	2320
2022 Q2	$15K	Hold	635	–	–	﹤0.01%	2384
2022 Q1	$32K	Hold	635	–	–	﹤0.01%	2283
2021 Q4	$45K	Sell	635 -265	-29%	-$22.3K	﹤0.01%	2190
2021 Q3	$84K	Buy	900 +564	+168%	+$53.6K	﹤0.01%	2038
2021 Q2	$34K	Sell	336 -45	-12%	-$4.39K	﹤0.01%	2243
2021 Q1	$36K	Buy	+381	New	+$38.6K	﹤0.01%	2152
2018 Q1	–	Sell	-70	Closed	-$9K	–	2411
2017 Q4	$9K	Buy	+70	New	+$8.61K	﹤0.01%	2287

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Macquarie Group's VBIV Position: Q4 2022 in Review

Macquarie Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 564 shares — an estimated $13K sold.

Macquarie Group first reported a position in VBIV in Q4 2017 and held it in 8 quarters. The position peaked at $84K in Q3 2021. 111 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

Macquarie Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
Macquarie Group sold 564 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $13K.
Macquarie Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 8 quarters.
Macquarie Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $84K in Q3 2021.
111 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.